ORION CHLORAL HYDRATE MIXTURE 1g/10mL bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion chloral hydrate mixture 1g/10ml bottle

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; saccharin sodium; glycerol; methyl hydroxybenzoate; ethanol; propylene glycol; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.

ORION PHENOBARBITAL ELIXIR phenobarbital 15mg/5mL oral liquid bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion phenobarbital elixir phenobarbital 15mg/5ml oral liquid bottle

orion laboratories pty ltd t/a perrigo australia - phenobarbital, quantity: 3 mg/ml - oral liquid, solution - excipient ingredients: purified water; ethanol; glycerol; sorbitol; flavour - indications as at 16 january 2002: treatment of epilepsy.

ORION DIAZEPAM 10mg/10mL oral liquid bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion diazepam 10mg/10ml oral liquid bottle

orion laboratories pty ltd t/a perrigo australia - diazepam, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: ethanol; propylene glycol; glycerol; citric acid; sodium citrate dihydrate; purified water; flavour - indications as at 30 september 2003: diazepam is indicated in the management of anxiety disorders and for the short term relief of the symptoms of anxiety. diazepam is a useful adjunct for the relief of reflux muscle spasm due to local trauma (injury, inflammation) to muscles, bones and joints. it is also indicated in the management of cerebral spasiticity due to upper motor neuron lesions such as cerebral palsy and paraplegia, and spasticity in athetosis and stiff man syndrome. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.

ORION CHLORAL HYDRATE MIXTURE 500mg/10mL bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion chloral hydrate mixture 500mg/10ml bottle

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 50 mg/ml - oral liquid, solution - excipient ingredients: glycerol; sucrose; anise oil; ethanol; methyl hydroxybenzoate; saccharin sodium; citric acid; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.

PARALAX LIQUID PARAFFIN EMULSION 2.5 mL/5 mL oral liquid bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

paralax liquid paraffin emulsion 2.5 ml/5 ml oral liquid bottle

orion laboratories pty ltd t/a perrigo australia - liquid paraffin, quantity: 500 microlitre/ml - oral liquid, emulsion - excipient ingredients: methylcellulose; saccharin sodium; purified water; benzoic acid; potassium sorbate; calcium cyclamate; flavour - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) for constipation.

PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

phebra naproxen suspension naproxen 125mg/5ml oral liquid bottle

phebra pty ltd - naproxen, quantity: 25 mg/ml - oral liquid, suspension - excipient ingredients: sorbitol solution (70 per cent) (crystallising); aluminium magnesium silicate; purified water; sucrose; sodium chloride; fumaric acid; methyl hydroxybenzoate; sunset yellow fcf; sodium hydroxide; flavour - treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, for the symptomatic treatment of primary dysmenorrhoea, for the relief of acute and/or chronic pain states in which there is an inflammatory component and as an analgesic in acute migraine attack.

CAFNEA ORAL SOLUTION caffeine citrate oral solution 25 mg/5 mL oral administration vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

cafnea oral solution caffeine citrate oral solution 25 mg/5 ml oral administration vial

phebra pty ltd - caffeine, quantity: 12.5 mg - oral liquid, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; water for injections - cafnea oral solution is indicated for the short-term treatment of apnoea of prematurity in infants between 28 and 33 weeks gestational age.

GIONA EASYHALER INHALATION POWDER 200 mcgdose Singapor - Ingliż - HSA (Health Sciences Authority)

giona easyhaler inhalation powder 200 mcgdose

orion pharma (sg) pte. ltd. - budesonide - powder, metered - 200 mcg/dose - budesonide 200 mcg/dose